MicroNet网状覆膜保护支架治疗颈动脉疾病:十年单中心经验
30天临床成功率100%,围术期无死亡、心肌梗死或卒中,1例短暂性脑缺血发作;中位随访37个月,60个月免于再狭窄率98%。
要点
- CGuard双层支架用于无症状颈动脉狭窄>70%患者,围术期无死亡、心梗或卒中。
- 30天临床成功率100%,平均手术时间29±8分钟,4%需非计划追加支架。
- 中位随访37个月,60个月免于再狭窄率98%,一期辅助通畅率100%。
核心结论
- CGuard双层支架行颈动脉支架置入术在无症状患者中技术成功率高、早期神经事件率低,中期通畅性持久。
研究设计与样本
- 主要终点为围术期任何死亡、卒中或心肌梗死的发生率。
- 次要终点包括技术成功、非计划追加颈动脉支架的必要性及手术时间,以反映CGuard支架释放的易行性与准确性。
- 同时评估免于再狭窄率和晚期神经结局,术后评估验证支架放置与病变覆盖是否与术前计划一致。
主要发现
- 30天临床成功率为100%,围术期无死亡、心肌梗死或卒中。
- 1例患者发生短暂性脑缺血发作。
- 平均手术时间为29±8分钟,4例(4%)需要非计划追加支架。
- 中位随访37个月,60个月总生存率为89%。
- 1例在22个月发生支架内狭窄,60个月免于再狭窄率为98%,一期辅助通畅率为100%。
临床怎么用
- 对于无症状颈动脉狭窄>70%患者,CGuard双层支架行颈动脉支架置入术可作为围术期风险低、中期通畅性好的选择。
- 术后评估需验证支架放置与病变覆盖是否与术前计划一致。
局限性
- 单中心回顾性研究设计。
- 仅纳入无症状颈动脉狭窄患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study evaluates the early and midterm safety outcomes of CGuard carotid artery stenting (CAS) for asymptomatic carotid artery disease, with a focus on the accuracy of intraoperative stent release. METHODS: We conducted a single-center retrospective study of patients undergoing CAS for asymptomatic carotid stenosis >70% (2015-2025) in a high-volume vascular. The primary end point was the perioperative rate of any death, stroke, or myocardial infarction. Secondary end points included technical success, the necessity for unplanned adjunctive carotid stenting, and operation time as indicators of the ease and accuracy of CGuard stent deployment. Freedom from restenosis and late neurological outcomes were also evaluated. Postoperative evaluations ensured alignment with preoperative planning, verifying stent placement and appropriate lesion coverage. Kaplan-Meier survival estimates of freedom from restenosis were assessed. RESULTS: One hundred ten patients were included (male 73%). The 30-day clinical success rate was 100%, with no perioperative deaths, myocardial infarctions, or strokes. One patient experienced a transient ischemic attack. The mean operation time was 29 ± 8 minutes, and 4 patients (4%) required additional unplanned stenting. The median follow-up was 37 months, with an overall survival rate of 89% at 60 months. One case of stent stenosis occurred at 22 months, with a 60-month freedom from restenosis rate of 98% and primary-assisted patency of 100%. CONCLUSION: CAS with the CGuard dual-layer stent was associated with high technical success, a low rate of early neurological event, and durable midterm patency in asymptomatic patients.
引用
- Forcella E, Mastrorilli D, De Massari C, et al. MicroNet Mesh-Covered Protection Stent for Carotid Artery Disease: Ten-Year Single-Center Experience. Ann Vasc Surg. 2026. PMID: 41796662. doi:10.1016/j.avsg.2026.02.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。